doi: 10.1016/S0140-6736(23)01053-X
Tirzepatide: This novel medication combines the effects of two different hormones involved in blood sugar regulation and appetite control
If the patient tolerates the initial dose well, the dose can be increased gradually
The catch is that qualification requirements can be strict, and patients on government insurance like Medicare or Medicaid are typically excluded
Key Takeaways: Triple-Action Mechanism : Retatrutide uniquely activates GLP-1, GIP, and glucagon receptors, profoundly enhancing weight loss, glycemic control, and metabolic flexibility
The net effect of this triple mechanism: appetite reduction + improved insulin signaling + increased energy expenditure + enhanced liver fat clearance